Paper35638331
Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease.
Yagyu H and 1 other. J Diabetes Investig, 2022. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease. Papers, record 35638331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35638331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Fruit | |
| Glucose | |
| Humans | |
| Hypoglycemic Agents | |
| Glucagon-Like Peptide-1 Receptor Agonists |
Source PubMed
References152
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25088437 | Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. | Lancet | 2014 | https://conductscience.org/library/papers/25088437 | PubMed |
| 2 | 21664294 | Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. | Vascul Pharmacol | 2011 | https://conductscience.org/library/papers/21664294 | PubMed |
| 3 | 12876091 | Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. | JAMA | 2003 | https://conductscience.org/library/papers/12876091 | PubMed |
| 4 | 21205121 | Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. | Diabetes Obes Metab | 2011 | https://conductscience.org/library/papers/21205121 | PubMed |
| 5 | 34364771 | Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials. | Nutr Metab Cardiovasc Dis | 2021 | https://conductscience.org/library/papers/34364771 | PubMed |
| 6 | 28431667 | The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes. | Diabetes Metab | 2017 | https://conductscience.org/library/papers/28431667 | PubMed |
| 7 | 26179504 | Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial. | Lancet Diabetes Endocrinol | 2015 | https://conductscience.org/library/papers/26179504 | PubMed |
| 8 | 34893404 | All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials. | Nutr Metab Cardiovasc Dis | 2022 | https://conductscience.org/library/papers/34893404 | PubMed |
| 9 | 31748169 | Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial. | Lancet Diabetes Endocrinol | 2019 | https://conductscience.org/library/papers/31748169 | PubMed |
| 10 | 35050311 | Cardiovascular Effects of Incretin-Based Therapies: Integrating Mechanisms With Cardiovascular Outcome Trials. | Diabetes | 2022 | https://conductscience.org/library/papers/35050311 | PubMed |
| 11 | 21366474 | Diabetes mellitus, fasting glucose, and risk of cause-specific death. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21366474 | PubMed |
| 12 | 20427682 | Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. | Diabetes Care | 2010 | https://conductscience.org/library/papers/20427682 | PubMed |
| 13 | 30424892 | SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. | Lancet | 2019 | https://conductscience.org/library/papers/30424892 | PubMed |
| 14 | 26343814 | Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes. | Diabetes Obes Metab | 2015 | https://conductscience.org/library/papers/26343814 | PubMed |
| 15 | 20937686 | A1C and cardiovascular outcomes in type 2 diabetes: a nested case-control study. | Diabetes Care | 2011 | https://conductscience.org/library/papers/20937686 | PubMed |
| 16 | 30259238 | Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect? | Curr Cardiol Rep | 2018 | https://conductscience.org/library/papers/30259238 | PubMed |
| 17 | 28402770 | Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28402770 | PubMed |
| 18 | 23230096 | Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. | Diabetes Care | 2013 | https://conductscience.org/library/papers/23230096 | PubMed |
| 19 | 23992602 | Alogliptin after acute coronary syndrome in patients with type 2 diabetes. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23992602 | PubMed |
| 20 | 30415602 | Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. | N Engl J Med | 2019 | https://conductscience.org/library/papers/30415602 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40883386 | Effect of GLP-1RA on coronary progression and cardiovascular outcomes in type 2 diabetic patients after PCI: a prospective cohort study. | Sci Rep | 2025 | https://conductscience.org/library/papers/40883386 | PubMed |
| 40540523 | PPARγ inhibitors enhance the efficacy of statin therapy for steroid-induced osteonecrosis of the femoral head by directly inhibiting apoptosis and indirectly modulating lipoprotein subfractions. | PLoS One | 2025 | https://conductscience.org/library/papers/40540523 | PubMed |
| 38389209 | Interplay of cardiovascular health and diabetes: Insights into weight management and risk reduction. | J Diabetes Investig | 2024 | https://conductscience.org/library/papers/38389209 | PubMed |
| 36631991 | Intensified Multifactorial Intervention in Patients with Type 2 Diabetes Mellitus. | Diabetes Metab J | 2023 | https://conductscience.org/library/papers/36631991 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADIPOQ | 9370 | PubTator's text mining | https://conductscience.org/library/genes/9370 | NCBI Gene |
| AP2B1 | 163 | PubTator's text mining | https://conductscience.org/library/genes/163 | NCBI Gene |
| DPP4 | 1803 | PubTator's text mining | https://conductscience.org/library/genes/1803 | NCBI Gene |
| EPO | 2056 | PubTator's text mining | https://conductscience.org/library/genes/2056 | NCBI Gene |
| GIP | 2695 | PubTator's text mining | https://conductscience.org/library/genes/2695 | NCBI Gene |
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| PPARG | 5468 | PubTator's text mining | https://conductscience.org/library/genes/5468 | NCBI Gene |
| SLC5A2 | 6524 | PubTator's text mining | https://conductscience.org/library/genes/6524 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35638331
GET https://conductscience.org/api/papers/v1/35638331/references?page=2